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AbstrAct
Objectives This study aims to provide a national 
picture of the extent and nature of public health 
services commissioned by local authorities (LAs) from 
community pharmacies across England in financial year 
2014/15.
Design Cross-sectional survey of public health services 
commissioned in community pharmacies by LAs, gathered 
via freedom of information requests and documentary 
analysis.
Setting and participants All 152 LAs in England.
Results A total of 833 commissioned services were 
reported across England (range 3–10 per LA). Four 
services were commissioned by over 90% of LAs: 
emergency hormonal contraception (EHC), smoking 
cessation support, supervised consumption of 
methadone or other opiates and needle and syringe 
programmes (NSPs). The proportion of pharmacies 
commissioned to deliver these services varied 
considerably between LAs from <10% to 100%. This 
variation was not related to differences in relevant proxy 
measures of need. NHS Health Checks and alcohol 
screening and brief advice were commissioned by 
fewer LAs (32% and 15%, respectively), again with no 
relationship to relevant measures of need. A range of 
other services were commissioned less frequently, by 
fewer than 10% of LAs. Supervised consumption and 
NSPs were the most frequently used services, with over 
4.4 million individual supervisions and over 1.4 million 
needle packs supplied. Pharmacies provided over 
200 000 consultations for supply of EHC, over 30 000 
supplies of free condoms and almost 16 000 chlamydia 
screening kits. More than 55 000 people registered to 
stop smoking in a community pharmacy, almost 30 000 
were screened for alcohol use and over 26 000 NHS 
Health Checks were delivered.
Conclusions There is significant variation in 
commissioning and delivery of public health services in 
community pharmacies across England, which correlate 
poorly with potential benefit to local populations. 
Research to ascertain reasons for this variation is 
needed to ensure that future commissioning and 
delivery of these services matches local need.
IntroductIon
National Government in England, commu-
nity pharmacy contractors’ representatives 
and pharmacy professional bodies have 
repeatedly expressed the desire for commu-
nity pharmacy to deliver public health 
interventions to help promote health and 
well-being in a wider population.1–5 Commu-
nity pharmacy’s particular strengths in 
providing such services have been suggested 
as follows: widening access to services, 
increasing patient's choice and the poten-
tial to reach underserved groups.5 Indeed, 
community pharmacies are accessible within 
a 20-min walk for almost 90% of the English 
population, with this rising to almost 100% 
for those areas in the most deprived decile.6 
Public health services are commissioned from 
community pharmacies through multiple 
mechanisms, including under the English 
Community Pharmacy Contractual Frame-
work, local pharmaceutical services contracts 
and commissioning through local authorities 
(LAs) and clinical commissioning groups.7 
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Research
Strengths and limitations of this study
 ► The study covered all local authorities (LAs) in 
England which commissioned community pharmacy 
public health services in 2014/15.
 ► Multiple sources were used to minimise missing 
data; hence, the number of services is complete, 
numbers of pharmacies providing services is 90% 
complete and usage data is 58% complete.
 ► The findings rely on the accuracy of the data 
supplied by LAs, which could not be verified.
 ► Relevant measures of population health were used to 
assess potential need for individual services across 
LA areas, but are recognised as a proxy measure.
 ► The study did not take account of similar service 
provision by other agencies.
group.bmj.com on July 18, 2017 - Published by http://bmjopen.bmj.com/Downloaded from 
2 Mackridge AJ, et al. BMJ Open 2017;7:e015511. doi:10.1136/bmjopen-2016-015511
Open Access 
Following the reorganisation of NHS Primary Care, LAs 
took primary responsibility from the former primary care 
trusts (PCTs) for commissioning of the majority of public 
health services. However, the commissioning landscape 
for pharmacies is complex and variable across England, 
with different ways of working and subcontracting of 
commissioning responsibilities operating in some areas.7 
Further, some services have been decommissioned8 in 
the face of resource challenges and lack of evidence of 
their effectiveness and cost-effectiveness.9 10 In addition, 
while pharmacy public health services are well accepted 
by users and the general public is willing to use them, 
awareness of the services offered and how to access them 
remains limited, potentially contributing to low usage 
and consequential decommissioning.11–15
Localised commissioning, coupled with this continual 
flux, has resulted in a mosaic of services being offered 
through pharmacies across the country. Pharmacists may 
provide a range of private services in addition to those 
which are commissioned and publicly funded,16 such as 
blood pressure monitoring and private weight manage-
ment services, but little is known about these on a national 
level. In addition, while most PCTs historically reported 
services commissioned to the Health and Social Care 
Information Centre (http://www. hscic. gov. uk) prior to 
the reorganisation of the NHS, some descriptor catego-
ries did not allow for individual services to be identified, 
further contributing to the lack of detailed information 
available. Since reorganisation, data reported publicly are 
very limited indeed. Local Pharmaceutical Committees 
are encouraged to provide data to a database maintained 
by the Pharmaceutical Services Negotiating Committee 
(PSNC) (http://www. psnc. org. uk), which is freely acces-
sible, and many commissioners encourage pharmacists to 
submit data to a national database, such as PharmOut-
comes (https://www. pharmoutcomes. org) and Service 
PACT (https://www. servicepact. co. uk). However, not 
all do so, for all services; thus, both sources of data are 
incomplete and neither is publicly available.
An analysis of the PSNC database in November 2015 
suggested that a total of 558 public health services were 
commissioned by LAs from pharmacies across England. 
The most common services identified were: supervised 
administration of opioid substitutes to treat drug addic-
tion, needle and syringe programmes (NSPs) and stop 
smoking services.17 However, this analysis relied on 
voluntary reporting to a database; thus, it was likely to 
be incomplete. More recently, in response to a proposal 
from the Department of Health to make significant 
funding cuts to the community pharmacy budget from 
December 2016, the PSNC commissioned a review of 
selected pharmacy services. Three public health services 
were included: supervised administration, NSP and emer-
gency hormonal contraception (EHC).18 This review 
made use of both the PSNC and PharmOutcomes data-
bases to estimate the volume and cost of delivering these 
services through community pharmacies in an attempt to 
assess their value to the NHS, society and users. However, 
pharmacy public health services are not limited to these 
three. A range of others are commissioned including 
smoking cessation, provision of free condoms, chlamydia 
screening and treatment, alcohol screening and brief 
advice, weight management, NHS Health Checks and 
vaccination services.17 A national picture of services is 
desirable to inform policy-makers and commissioners of 
both the overall extent of provision and variation across 
the country.
This study sought to obtain information about the 
extent of such provision through requests to LA commis-
sioners under the Freedom of Information Act 2000, 
which provides public right of access to information held 
by public authorities.
Aim
This study aims to describe the extent of, and variation 
within, LA-commissioned pharmacy public health services 
across England.
Methods
We sent a freedom of information (FOI) request to all 
152 LAs in England in July 2015, requesting details of 
any public health services commissioned from commu-
nity pharmacies in their authority. The authorities that 
failed to respond, and those which directed us to their 
published Pharmaceutical Needs Assessment (PNA) docu-
ments, were sent a second, shorter request in February 
2016 that focused on numbers of pharmacies commis-
sioned and the number of service episodes completed. 
Some LAs failed to provide the relevant data after two 
requests and, in order to provide as complete a picture as 
possible, we approached the owners of PharmOutcomes 
(Pinnacle Health in partnership with Health Information 
Exchange) and Service PACT (Webstar Health) (two data 
packages supporting delivery of community pharmacy 
services) to supplement the data.
data handling and analysis
We determined the number of different public health 
services commissioned, numbers of pharmacies commis-
sioned and service usage for each LA. For non-responding 
LAs and where data were missing, we extracted data on 
services commissioned and the numbers of pharmacies 
commissioned, where available, from the PNA for each 
LA. To protect confidentiality, available usage data from 
the pharmacy data suppliers were added in aggregate 
form only and none is identifiable to a particular LA. The 
definitions we used to estimate usage were relevant to the 
nature of each service and are listed in table 1.
We calculated the total number of different public 
health services commissioned for England and for each 
LA. The numbers of community pharmacies in England 
and in each LA were obtained from the Local Govern-
ment Authority website (http:// lginform. local. gov. uk/ 
reports/ lgastandard? mod- metric= 3706& mod- period= 
1& mod- area= E92000001& mod- group= AllLaInCountry_ 
England), enabling the proportion of pharmacies 
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Table 1 Definitions used for estimation of service usage
Service Definition of service use
Emergency hormonal 
contraception
Number of consultations (and 
number of supplies if available)
Chlamydia screening Number of screening kits provided 
(and returned to laboratory if 
available)
Chlamydia treatment Number of treatment episodes
Free condoms Number of registered users
Supervised consumption Number of individual supervisions
Needle and syringe 
programmes
Number of needle packs
Smoking cessation Number of registered users (plus 
4-week quitters if available)
NHS Health Checks Number of Health Checks
Alcohol screening Number of screens
Weight management Number of registered users
Healthy Start vitamin 
supply
Number of registered users and 
number of supplies
providing services across England, and within each LA, 
to be calculated. Population health data relevant to the 
services provided were obtained from PHE (https://www. 
gov. uk/ guidance/ phe- data- and- analysis- tools) to enable 
us to compare distribution of services to proxy measures 
of health need. The correlations (Spearman’s correlation 
coefficient) between datasets which we explored were: 
EHC provision against under 18 pregnancy rate, smoking 
support services against adult smoking rates, supervised 
consumption and NSP provision against deaths from 
substance use, alcohol screening against alcohol-re-
lated adult hospital admissions and NHS Health Checks 
against diabetes prevalence and under-75 cardiovascular 
mortality.
NHS England commissioned an influenza and pneu-
mococcal vaccination service across all London boroughs 
in the winter of 2014/15 involving 1272 pharmacies. 
To calculate the number of pharmacies across England 
providing influenza vaccination, we combined these 
figures with data obtained from LAs outside London. 
However, as no usage data were available for the London 
service, it was not possible to determine national usage.
Approval by an NHS Research Ethics Committee 
was not necessary as no patients, users or carers were 
involved and no patient identifiable data were included 
in this project. Further, no approvals were required under 
research governance arrangements as no NHS organisa-
tions were included in the project.
results
Response rate
The overall response rate was 146/152 (96.0%): 127 
usable responses to the first request and 17 to the second 
(two indicated that services were commissioned by third 
parties and provided no data). Four LAs indicated that 
services were commissioned by a neighbouring authority; 
thus, usable responses were obtained from 144 of the 148 
commissioning authorities (97.3%).
Usage data were not provided by 26 LAs. However, 
PharmOutcomes and Service PACT were able to supply 
data for at least one service for 14 of these, resulting in 
just 12/148 LAs (8%) with no usage data for any service.
Overview of commissioned services
Information on the services commissioned was available 
for all 148 LAs, either from the FOI responses or from 
PNAs. A total of 833 services were reported as being 
commissioned, with those reported most frequently 
covering sexual health, services to people who use 
drugs (NSPs and supervised consumption) and smoking 
cessation (additional datafile 1). Relatively few authori-
ties commissioned services relating to cardiovascular 
screening, lifestyle-related services or vaccinations. There 
were at least five services commissioned in 80% of all LAs, 
with a median of five services per LA (range 3–10).
Of the 833 services, 130 (15.5%) were explicitly stated, 
or appeared, to be commissioned indirectly through 
third parties, such as via Drug and Alcohol Teams or inte-
grated NHS trusts. This was most common for services to 
people who use drugs and smoking cessation, but some 
sexual health services were also externally commissioned, 
as were some small-scale services (figure 1). Data on the 
number of pharmacies providing commissioned services 
in each LA were 91% complete, with least data avail-
able for rarely commissioned services. table 2 shows the 
proportion of pharmacies commissioned in England as a 
whole for the range of services and also illustrates the vari-
ation across LAs. Significant variation across NHS Area 
teams was apparent for all major services (additional data-
file 2). Fewer data were obtained on service use across the 
LAs (58%) (table 2), but the available data do illustrate 
both the extent to which the services are accessed and the 
variation across LAs.
Individual services
Almost all LAs reported commissioning at least one phar-
macy sexual health service (144; 97%), with the most 
widespread service being EHC, being commissioned 
in 144 LAs (97%) and provided by at least 47% (5529) 
of the 11 819 pharmacies registered in England at 29 
November 2014. Chlamydia screening/treatment was 
available in 95 (64%) LAs with at least 28% of pharmacies 
(3315) providing this service. There were five LAs where 
an oral contraception service was commissioned, and one 
commissioned a fitting service for long-acting reversible 
contraception across three pharmacies. Pregnancy testing 
was also mentioned as a service by several LAs, but it was 
more frequently incorporated into an integrated sexual 
health service.
Supervised consumption of opioid substitution therapy 
was the most frequently reported service for people who 
use drugs and was commissioned by all 148 LAs, provided 
by over half of all pharmacies in England (6186; 52%). 
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Figure 1 Number of local authorities (LAs) commissioning each service directly or indirectly (n=148) (*Flu vaccination data 
excludes the service commissioned across London). NHS, National Health Service; TB, tuberculosis.
NSPs were commissioned from pharmacies in 145 (98%) 
LAs, although the number of pharmacies providing this 
service was much lower than supervised consumption at 
20% (2315).
Smoking cessation was by far the most frequently 
commissioned lifestyle modification service, in 133 (90%) 
of LAs, and provided by 5660 pharmacies in England 
(48%). Only 22 LAs (15%) had commissioned an alcohol 
screening and brief intervention service and six (4%) 
commissioned weight management services, while NHS 
Health Checks were commissioned by 48 (32%) LAs.
Only 13 LAs outside London reported that they commis-
sioned an influenza vaccination service, but five of these 
were specifically for staff employed by LAs. Assuming that 
all 33 London boroughs were commissioned to provide 
this service, a total of 46 LAs (31%) had a commissioned 
service, involving 1531 pharmacies (in 44 of the 46 LAs). 
Two other LAs commissioned vaccination against hepatitis 
B. Among other smaller scale services, 10 LAs commis-
sioned pharmacies to provide Healthy Start vitamins 
through the NHS voucher scheme, five commissioned 
testing for HIV, a further three commissioned screening 
services for blood-borne viruses (potentially covering 
both HIV and hepatitis B and C) and two commissioned 
directly observed treatment for tuberculosis.
Comparison to population health data
The variation in the proportion of pharmacies within 
LAs across England providing services to people who use 
drugs, EHC, smoking cessation, alcohol screening and 
NHS Health Checks showed poor correlations with rele-
vant measures of population health in these LAs (table 3 
and additional datafile 3). For example, 14 LAs did not 
report a commissioned pharmacy smoking cessation 
service, seven of which had adult smoking rates above the 
national average, while in 16 out of 61 other LAs (26%) 
with above-average smoking rates, fewer than 50% of phar-
macies provided a service. Only 48 LAs commissioned 
NHS Health Checks in pharmacies, 31 (65%) of these 
were in areas with below-average diabetes prevalence 
and 29 (60%) in areas with lower than average cardio-
vascular mortality rates. Of the 30 areas with the highest 
cardiovascular mortality rates, only six had commis-
sioned pharmacies to provide NHS Health Checks, in 
contrast to 14 of the 30 LAs (47%) with the lowest rates 
commissioning services. Only nine (41%) of the 22 LAs 
commissioning alcohol screening from pharmacies had 
above-average rates of alcohol-related hospital stays.
dIscussIon
The commissioning, subsequent provision and uptake 
of public health services in pharmacies is highly variable 
across England, with a wide range in number of services 
commissioned and in the proportion of pharmacies 
providing these within each LA. However, four services 
(EHC, smoking cessation support, supervised consump-
tion of methadone or other medicines and NSPs) were 
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Table 3 Correlations between proportion of pharmacies commissioned to provide services and population health data for 
local authorities in England
Pharmacy service Health data
Correlation 
(Spearman’s r) n p Value
EHC Under 18 pregnancy rate 0.161 140 0.057
Chlamydia screening New sexually transmitted infections −0.078 88 0.467
Supervised consumption Deaths from substance use 0.113 79 0.321
Needle and syringe programmes Deaths from substance use −0.055 77 0.633
Smoking cessation support Adult smoking rate 0.156 130 0.076
NHS Health Checks Diabetes prevalence 0.244 45 0.107
NHS Health Checks Under-75 cardiovascular mortality −0.146 45 0.338
Alcohol screening/intervention Hospital admissions related to alcohol in adults 0.321 23 0.135
EHC, emergency hormonal contraception; NHS, National Health Service.
all commissioned by at least 90% of LAs, with the first 
three being provided by at least 45% of all pharmacies 
in England. Supervised consumption and NSPs were the 
most frequently used service, with over 4.4 million indi-
vidual supervisions and over 1.4 million needle packs 
supplied. There were over 200 000 consultations with 
a pharmacist for supply of EHC, over 30 000 received 
supplies of free condoms and almost 16 000 received chla-
mydia screening kits provided by a pharmacy. Over 55 000 
people registered to stop smoking in a community phar-
macy, almost 30 000 were screened for alcohol use and 
over 26 000 NHS Health Checks were carried out in 
pharmacies. However, commissioning of services did not 
appear to relate well to potential for benefit, estimated 
via local population health measures; indeed, for several 
services, the correlations obtained were negative.
This study provides the most comprehensive picture of 
public health services commissioned by English LAs from 
community pharmacies to date, covering the financial 
year 2014/15. A high response rate from the 148 commis-
sioning LAs was achieved, some data being provided by 
144 (97.3%), with much missing data obtained from other 
sources; thus, the range of commissioned services across 
all LAs is complete, the number of pharmacies providing 
services is 90.2% complete (available for 751/833 services) 
and data on service usage are 57.5% complete (479/833 
services).
The data on services commissioned on behalf of LAs 
by other agencies may also be incomplete, although 
the FOI requests did seek information on indirectly 
commissioned services. The study also did not attempt 
to seek information on services commissioned by Clinical 
Commissioning Groups, services relating to medicines 
support provided under the national community phar-
macy contractual framework or minor ailments services. 
The data requested covered the financial year 1 April 2014 
to 31 March 2015, and we had to rely on the accuracy of 
the data provided in responses to FOI requests and avail-
able in PNAs, as it was not possible to corroborate these 
against other sources of data. The analysis assumes that 
services were provided throughout the year; thus, some 
data may contain inaccuracies, caused by the dynamic 
nature of commissioning and provision of services. Our 
study relates only to the particular commissioning struc-
ture used in England; thus, the findings are only of direct 
relevance to this setting and not generalisable to other 
countries. However, the need to include community 
pharmacy in strategic planning of services to meet local 
health needs is relevant to anywhere that they form a part 
of the public health service landscape.
The study did not take account of the provision of similar 
services by other agencies, so it is possible that local health 
needs were being met through other service providers. 
Relevant measures of population health were used to 
assess potential health need for individual services across 
LA areas, but these are recognised as a proxy measure. 
Also, the cross-sectional nature of the study and the corre-
sponding data on health need mean that it is not possible 
to fully describe the relationship between the two. However, 
the intention of including these data is to illustrate the 
disconnect between the apparent health need and the 
provision of services through community pharmacies and 
not to suggest any causative relationship.
There are few published data on the commissioning or 
provision of these services. The most recent data available 
from the Health and Social Care Information Centre covered 
the period before the reorganisation of primary care in 
April 2013, and data were available for only three services in 
financial year 2012/13 (supervised consumption of opioid 
substitution therapy, NSPs and smoking cessation) and 
were also incomplete, being available for only 137 of the 
153 commissioning trusts in England at the time. In this 
year, 51% of pharmacies provided supervised consumption, 
20% provided NSPs and 55% provided smoking cessation 
services. There appears to be little change in these propor-
tions in 2014/15, being 52%, 20% and 48%, respectively. 
Our data indicate that the report in November 2015, which 
estimated that supervised consumption was commissioned 
in 89 LAs, NSPs were commissioned in 86, stop smoking 
services were commissioned in 88, EHC was commissioned 
in 71 and chlamydia screening was commissioned in 47,17 
was a significant underestimate. More recently, estimates 
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based on data provided to PSNC indicated that supervised 
administration was commissioned in 130 LAs, NSPs were in 
111 and EHC was in 131.18 This too appears to underesti-
mate the extent of commissioning; however, the estimate 
of 6158 pharmacies providing supervised consumption 
given in this report is in line with our findings (6186). The 
variation found here is in contrast to the nationally commis-
sioned influenza vaccination service introduced in 2015/16, 
which involved a total of 7195 pharmacies, which provided 
595 467 vaccinations, with the proportion of pharmacies 
providing the service across NHS area teams ranging from 
53% to 76%.19
Community pharmacy has long been championed as a 
potential setting for the delivery of public health services 
to significant sectors of the communities in which they 
are located, primarily because of their accessibility. 
While a few key services are widely commissioned from 
community pharmacies by LAs and are extensively used, 
there is significant variation in the distribution of these 
services, which appears to be poorly correlated to poten-
tial need. Other services such as NHS Health Checks and 
screening for risky alcohol use, for which there is less 
evidence of benefit, are much less frequently commis-
sioned but again are not concentrated in areas where the 
local community is most likely to benefit. The reasons for 
the variation we have found are not clear, from our work 
or the available literature, but do warrant investigation. 
There is a need to re-visit the benefits of local commis-
sioning of these services, which may be influenced by a 
range of factors other than identified need. The poor, 
sometimes negative, correlations we found suggest that 
commissioners should consider more strategically how 
community pharmacies could most usefully contribute to 
addressing local public health issues. Regional or national 
approaches to commissioning, designed to allow flexi-
bility in the extent of service provision based on differing 
needs, but using common service specification structures 
and data templates, could facilitate better large-scale 
data gathering. As our study shows, this is not the case 
with the current situation.
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